Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Nov;1(6):660–666. doi: 10.1128/cdli.1.6.660-666.1994

Rapid culture and quantitation of human immunodeficiency virus type 1 from patient cells without the use of mitogen-stimulated donor cells.

P K Kim 1, S He 1, J L HO 1
PMCID: PMC368385  PMID: 8556517

Abstract

We report the development of a rapid, sensitive virus culture method for direct quantitation of human immunodeficiency virus (HIV) in peripheral blood mononuclear cells (PBMCs). This new method involves culturing 10(7) PBMCs from HIV-seropositive persons in 10 ml of medium containing phorbol 12-myristate 13-acetate and interleukin-2. Both agents stimulate cell activation and hence viral replication. Cell-associated virus and free virus are quantitated by a commercially available HIV p24 antigen capture enzyme immunoassay. Detection of cell-associated p24 antigen by flow cytometry was less sensitive than by the enzyme immunoassay. In this preliminary study, HIV was detected in 20 of 23 HIV-seropositive patients and in none of the 11 HIV seronegative low-risk individuals. One HIV-seronegative person with Guillain-Barré syndrome following high-risk activity was found to be rapid-HIV-culture positive. The overall sensitivity and specificity were 87 and 100%, respectively. By comparing the quantity of virus produced in infected cells with the amount of virus produced in chronically infected U1 monocytes and ACH-2 lymphocytes stimulated with phorbol 12-myristate 13-acetate and interleukin-2, the approximate number of infected cells per sample is calculated. In the same patient specimens, quantitation of the number of HIV infected cells by the HIV rapid-culture method correlated with the results of the 21-day cell dilution coculture assay (correlation coefficient r = 0.5; 95% confidence interval, 0.07 to 0.77). Advantages of the rapid HIV culture include no requirement for donor PBMCs or change of media, shortened culture time, and the ability to detect p24 viral antigen from cell-associated virus for quantitation of viral load.

Full text

PDF
660

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alimenti A., O'Neill M., Sullivan J. L., Luzuriaga K. Diagnosis of vertical human immunodeficiency virus type 1 infection by whole blood culture. J Infect Dis. 1992 Nov;166(5):1146–1148. doi: 10.1093/infdis/166.5.1146. [DOI] [PubMed] [Google Scholar]
  2. Bieniasz P. D., Ariyoshi K., Bourelly M. A., Bloor S., Foxall R. B., Harwood E. C., Weber J. N. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV-1-infected individuals. AIDS. 1993 Jun;7(6):803–806. doi: 10.1097/00002030-199306000-00007. [DOI] [PubMed] [Google Scholar]
  3. Boutitie F., Pocock S. J. Predictive value of repeated measurements of CD4 lymphocyte counts on progression to AIDS. AIDS. 1994 Jan;8(1):35–41. doi: 10.1097/00002030-199401000-00006. [DOI] [PubMed] [Google Scholar]
  4. Bruisten S. M., Koppelman M. H., Roos M. T., Loeliger A. E., Reiss P., Boucher C. A., Huisman H. G. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments. AIDS. 1993 Nov;7 (Suppl 2):S15–S20. doi: 10.1097/00002030-199311002-00005. [DOI] [PubMed] [Google Scholar]
  5. Butera S. T., Roberts B. D., Folks T. M. Regulation of HIV-1 expression by cytokine networks in a CD4+ model of chronic infection. J Immunol. 1993 Jan 15;150(2):625–634. [PubMed] [Google Scholar]
  6. Bylund D. J., Ziegner U. H., Hooper D. G. Review of testing for human immunodeficiency virus. Clin Lab Med. 1992 Jun;12(2):305–333. [PubMed] [Google Scholar]
  7. Castro B. A., Weiss C. D., Wiviott L. D., Levy J. A. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J Clin Microbiol. 1988 Nov;26(11):2371–2376. doi: 10.1128/jcm.26.11.2371-2376.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choi S., Lagakos S. W., Schooley R. T., Volberding P. A. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med. 1993 May 1;118(9):674–680. doi: 10.7326/0003-4819-118-9-199305010-00003. [DOI] [PubMed] [Google Scholar]
  9. Clouse K. A., Powell D., Washington I., Poli G., Strebel K., Farrar W., Barstad P., Kovacs J., Fauci A. S., Folks T. M. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol. 1989 Jan 15;142(2):431–438. [PubMed] [Google Scholar]
  10. Cohen J. Searching for markers on the AIDS trail. Science. 1992 Oct 16;258(5081):388–390. doi: 10.1126/science.1357750. [DOI] [PubMed] [Google Scholar]
  11. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest. 1993 May;68(5):499–508. [PubMed] [Google Scholar]
  12. Coombs R. W., Collier A. C., Allain J. P., Nikora B., Leuther M., Gjerset G. F., Corey L. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989 Dec 14;321(24):1626–1631. doi: 10.1056/NEJM198912143212402. [DOI] [PubMed] [Google Scholar]
  13. Cullen B. R., Greene W. C. Regulatory pathways governing HIV-1 replication. Cell. 1989 Aug 11;58(3):423–426. doi: 10.1016/0092-8674(89)90420-0. [DOI] [PubMed] [Google Scholar]
  14. Duh E. J., Maury W. J., Folks T. M., Fauci A. S., Rabson A. B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974–5978. doi: 10.1073/pnas.86.15.5974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ferre F., Marchese A. L., Griffin S. L., Daigle A. E., Richieri S. P., Jensen F. C., Carlo D. J. Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatment. AIDS. 1993 Nov;7 (Suppl 2):S21–S27. doi: 10.1097/00002030-199311002-00006. [DOI] [PubMed] [Google Scholar]
  16. Folks T. M., Justement J., Kinter A., Dinarello C. A., Fauci A. S. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science. 1987 Nov 6;238(4828):800–802. doi: 10.1126/science.3313729. [DOI] [PubMed] [Google Scholar]
  17. Folks T. M., Justement J., Kinter A., Schnittman S., Orenstein J., Poli G., Fauci A. S. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol. 1988 Feb 15;140(4):1117–1122. [PubMed] [Google Scholar]
  18. Folks T., Benn S., Rabson A., Theodore T., Hoggan M. D., Martin M., Lightfoote M., Sell K. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4539–4543. doi: 10.1073/pnas.82.13.4539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harry D. J., Jennings M. B., Yee J., Carlson J. R. Antigen detection for human immunodeficiency virus. Clin Microbiol Rev. 1989 Jul;2(3):241–249. doi: 10.1128/cmr.2.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ho D. D., Moudgil T., Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. doi: 10.1056/NEJM198912143212401. [DOI] [PubMed] [Google Scholar]
  21. Ho J. L., Klempner M. S. Diminished activity of protein kinase C in tetanus toxin-treated macrophages and in the spinal cord of mice manifesting generalized tetanus intoxication. J Infect Dis. 1988 May;157(5):925–933. doi: 10.1093/infdis/157.5.925. [DOI] [PubMed] [Google Scholar]
  22. Holzer T. J., Heynen C. A., Novak R. M., Pitrak D. L., Dawson G. J. Frequency of cells positive for HIV-1 p24 antigen assessed by flow cytometry. AIDS. 1993 Nov;7 (Suppl 2):S3–S5. doi: 10.1097/00002030-199311002-00002. [DOI] [PubMed] [Google Scholar]
  23. Jackson J. B., Kwok S. Y., Sninsky J. J., Hopsicker J. S., Sannerud K. J., Rhame F. S., Henry K., Simpson M., Balfour H. H., Jr Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol. 1990 Jan;28(1):16–19. doi: 10.1128/jcm.28.1.16-19.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kinter A. L., Poli G., Maury W., Folks T. M., Fauci A. S. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol. 1990 Sep;64(9):4306–4312. doi: 10.1128/jvi.64.9.4306-4312.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kojima E., Shirasaka T., Anderson B., Chokekijchai S., Sei S., Yarchoan R., Mitsuya H. Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription. AIDS. 1993 Nov;7 (Suppl 2):S101–S105. doi: 10.1097/00002030-199311002-00019. [DOI] [PubMed] [Google Scholar]
  26. Lee T. H., Sheppard H. W., Reis M., Dondero D., Osmond D., Busch M. P. Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr. 1994 Apr;7(4):381–388. [PubMed] [Google Scholar]
  27. Legrand-Poels S., Vaira D., Pincemail J., van de Vorst A., Piette J. Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1389–1397. doi: 10.1089/aid.1990.6.1389. [DOI] [PubMed] [Google Scholar]
  28. Levy J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993 Mar;57(1):183–289. doi: 10.1128/mr.57.1.183-289.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McSharry J. J., Costantino R., Robbiano E., Echols R., Stevens R., Lehman J. M. Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry. J Clin Microbiol. 1990 Apr;28(4):724–733. doi: 10.1128/jcm.28.4.724-733.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Miles S. A., Balden E., Magpantay L., Wei L., Leiblein A., Hofheinz D., Toedter G., Stiehm E. R., Bryson Y. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med. 1993 Feb 4;328(5):297–302. doi: 10.1056/NEJM199302043280501. [DOI] [PubMed] [Google Scholar]
  31. Moss A. R. Laboratory markers as potential surrogates for clinical outcomes in AIDS trials. J Acquir Immune Defic Syndr. 1990;3 (Suppl 2):S69–S71. [PubMed] [Google Scholar]
  32. Mufson R. A., Myers C., Turpin J. A., Meltzer M. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells. J Leukoc Biol. 1992 Dec;52(6):637–644. doi: 10.1002/jlb.52.6.637. [DOI] [PubMed] [Google Scholar]
  33. Osborn L., Kunkel S., Nabel G. J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336–2340. doi: 10.1073/pnas.86.7.2336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ou C. Y., McDonough S. H., Cabanas D., Ryder T. B., Harper M., Moore J., Schochetman G. Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes. AIDS Res Hum Retroviruses. 1990 Nov;6(11):1323–1329. doi: 10.1089/aid.1990.6.1323. [DOI] [PubMed] [Google Scholar]
  35. Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. doi: 10.1126/science.8096089. [DOI] [PubMed] [Google Scholar]
  36. Poli G., Fauci A. S. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses. 1992 Feb;8(2):191–197. doi: 10.1089/aid.1992.8.191. [DOI] [PubMed] [Google Scholar]
  37. Poli G., Kinter A. L., Fauci A. S. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):108–112. doi: 10.1073/pnas.91.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Poli G., Kinter A., Justement J. S., Kehrl J. H., Bressler P., Stanley S., Fauci A. S. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci U S A. 1990 Jan;87(2):782–785. doi: 10.1073/pnas.87.2.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Poli G., Orenstein J. M., Kinter A., Folks T. M., Fauci A. S. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989 May 5;244(4904):575–577. doi: 10.1126/science.2470148. [DOI] [PubMed] [Google Scholar]
  40. Saksela K., Stevens C., Rubinstein P., Baltimore D. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1104–1108. doi: 10.1073/pnas.91.3.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schechter M., Harrison L. H., Halsey N. A., Trade G., Santino M., Moulton L. H., Quinn T. C. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA. 1994 Feb 2;271(5):353–357. [PubMed] [Google Scholar]
  42. Schochetman G., Epstein J. S., Zuck T. F. Serodiagnosis of infection with the AIDS virus and other human retroviruses. Annu Rev Microbiol. 1989;43:629–659. doi: 10.1146/annurev.mi.43.100189.003213. [DOI] [PubMed] [Google Scholar]
  43. Schreck R., Grassmann R., Fleckenstein B., Baeuerle P. A. Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein. J Virol. 1992 Nov;66(11):6288–6293. doi: 10.1128/jvi.66.11.6288-6293.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 Aug;10(8):2247–2258. doi: 10.1002/j.1460-2075.1991.tb07761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schüpbach J., Jendis J. B., Bron C., Böni J., Tomasik Z. False-positive HIV-1 virus cultures using whole blood. AIDS. 1992 Dec;6(12):1545–1546. doi: 10.1097/00002030-199212000-00022. [DOI] [PubMed] [Google Scholar]
  46. Valge V. E., Wong J. G., Datlof B. M., Sinskey A. J., Rao A. Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell. 1988 Oct 7;55(1):101–112. doi: 10.1016/0092-8674(88)90013-x. [DOI] [PubMed] [Google Scholar]
  47. Volberding P. A. HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship. JAMA. 1994 Feb 2;271(5):392–393. [PubMed] [Google Scholar]
  48. Wages J. M., Jr, Hamdallah M., Calabro M. A., Fowler A. K., Oster C. N., Redfield R. R., Burke D. S. Clinical performance of a polymerase chain reaction testing algorithm for diagnosis of HIV-1 infection in peripheral blood mononuclear cells. J Med Virol. 1991 Jan;33(1):58–63. doi: 10.1002/jmv.1890330112. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES